NANCY DELACRUZ: Open Payments
NPI 1568419653 · SHAWNEE MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 43 payments from 9 companies in 2025. Trend: 2023 $390 · 2024 $573 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 31 | $310 |
| Calliditas Therapeutics US Inc. | 2 | $76 |
| Fresenius USA Marketing, Inc. | 3 | $52 |
| AKEBIA THERAPEUTICS INC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Amgen Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: TARPEYO, VELPHORO, Vafseo, Fabhalta, KRYSTEXXA, JYNARQUE, Ozempic, BENLYSTA.
Industry payments across KS — which companies pay providers there.
